Pacific Biosciences Of California | PACB - 资产



金融业
股票价格
USD
资产
USD 782.37M
现金及等价物
USD 56.27M
销售成本
USD 28.9M
流动资产
USD 369.52M
流动负债
USD 65.36M
债务
USD 892.24M
股息收益率
0
EBIT
USD -53.19M
EBITDA
USD -35.4M
员工
796
EPS每股收益
USD -0.17
股本和储备
USD 2.37M
销售毛利
USD 15.74M
债务利息支出
USD 1.74M
贷款资金
USD 645.38M
市值
USD 431.4M
净收入
USD -40.37M
营业费用
USD 97.83M
营业利润
USD -53.19M
普通股股本
USD 301.96M
税前利润
USD -40.17M
销售收入
USD 44.65M
销售和管理费用
USD 37.24M
股票
USD 51.02M
贸易债权人
USD 13.61M
应收帐款人
USD 35.45M


资产 更改 日
Agilent USD 13.07B 252M 2026-03
Bruker USD 6.13B 110.7M 2026-03
Danaher USD 83.54B 80M 2026-03
General Electric Aerospace USD 128.45B 1.72B 2026-03
Illumina USD 6.56B 85M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
Pacific Biosciences Of California USD 782.36M 1.72M 2026-03
Quidel USD 5.63B 140.6M 2026-03
Revvity USD 12B 171.82M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Standard Biotools USD 639.11M 71.36M 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Waters USD 24.53B 19.45B 2026-03